Table 2.
Patient demographics (multiple‐dose administration)
| Treatment | ||||||
|---|---|---|---|---|---|---|
| Characteristic | Statistic | Placebo (n = 10) | 3 mg (n = 6) | 10 mg (n = 6) | 20 mg (n = 6) | All subjects (n = 29) |
| Sex (female) | n (%) | 2 (20·0) | 2 (33·3) | 1 (14·3) | 3 (50·0) | 8 (27·6) |
| Race (Caucasian) | n (%) | 8 (80·0) | 4 (66·7) | 6 (85·7) | 6 (100·0) | 24 (82·8) |
| Age (years) | Mean (SD) | 36·7 (16·0) | 25·3 (4·5) | 28·6 (13·6) | 53·0 (16·9) | 35·8 (16·6) |
| Height (inches) | Mean (SD) | 67·69 (2·09) | 67·21 (4·20) | 69·17 (4·49) | 66·66 (4·55) | 67·73 (3·66) |
| Weight (pounds) | Mean (SD) | 162·95 (20·72) | 166·05 (36·64) | 170·08 (20·72) | 172·17 (31·68) | 167·22 (25·75) |
| BMI (kg/m2) | Mean (SD) | 25·14 (3·52) | 25·65 (3·41) | 25·20 (2·56) | 27·18 (3·13) | 25·68 (3·14) |
BMI, body mass index; SD, standard deviation.